Jump to search

January 2017arrow

Many late-stage lung cancer patients do not get treatment

January 18, 2017

A national study by researchers at UC Davis Comprehensive Cancer Center has found that a significant number of lung cancer patients are not receiving treatment. Based on data between 1998 and 2012 from the National Cancer Database, 21 percent of patients (190,539) with non-small cell lung cancer (NSCLC) received no specific cancer treatment, such as chemotherapy, radiotherapy or surgery. Many of the untreated patients were women, elderly, minorities, low income and uninsured.

UC Davis Health welcomes Beijing medical equipment company

January 9, 2017

UC Davis Health has entered into an agreement with Top Grade Health Care to establish a translational research and development center to advance the treatment of patients with cancer.

December 2016arrow

UC Davis MIND Institute part of national study on video game-like therapy for ADHD

December 28, 2016

The UC Davis MIND Institute is participating in a nationwide ADHD study using a scientifically designed video game-like technology.

Shift in some teens' use and perceptions of marijuana after recreational marijuana is legalized

December 27, 2016

Marijuana use significantly increased and its perceived harm decreased among eighth- and 10th-graders in Washington state following enactment of recreational marijuana laws, according to a UC Davis and Columbia University Mailman School of Public Health to be published online in JAMA Pediatrics. There was no change in use or perceived harm among 12th graders or among similar grades in Colorado.

Genomic sequencing illuminates recent Shigella outbreaks in California

December 22, 2016

In a study that could have significant impact on how disease outbreaks are managed, researchers at UC Davis and the California Department of Public Health (CDPH) have sequenced and analyzed genomes from Shigella sonnei (S. sonnei) bacteria associated with major shigellosis outbreaks in California in 2014 and 2015.

Study identifies who could benefit most from exercise as a depression treatment

December 21, 2016

Factors such as advanced age and greater aerobic capacity increase the likelihood that exercise will work as a treatment for depression in elderly patients, a recent study published in the Journal of the American Geriatrics Society has shown.

UC program excels at reducing hospital blood clots

December 15, 2016

Results of a UC-wide venous thromboembolism (VTE) prevention program, led by Gregory Maynard, chief quality officer for UC Davis Medical Center, have shown a significant reduction in hospital-associated VTEs at all five participating UC hospitals, according to a recently released study authored by Maynard and published in the December 2016 issue of the Journal of Hospital Medicine.

Fragile X drug trial gets $11.5 million in NIH funding

December 15, 2016

The UC Davis MIND Institute and Rush University Medical Center have been awarded $11.5 million from the National Institutes of Health to test a new therapy designed to improve language learning for children fragile X syndrome. 

Hormonal contraception is safer than expected for women with diabetes

December 14, 2016

Strokes and heart attacks are rare for women with diabetes who use hormonal contraception, with the safest options being intrauterine devices (IUDs) and under-the-skin implants, new research published in Diabetes Care shows.

Genetics and environment combine to influence autism-associated genes

December 13, 2016

Researchers at UC Davis have shown that a well-known neurotoxin (PCB 95) and a chromosomal duplication (Dup15q) have a profound impact on DNA methylation, the epigenetic process that can influence gene activity. These cumulative genetic and environmental “hits” alter the epigenetic landscape during development, altering genes linked to autism spectrum disorder (ASD). The study was published in the journal Cell Reports.

Immunotherapy improves survival in late-stage lung cancer patients

December 12, 2016

A large trial by UC Davis professor David Gandara has found that the immunotherapy atezolizumab was superior to chemotherapy for patients with advanced non-small-cell lung cancer.

Healthy weight only protects women from hot flashes during the early stages of menopause

December 6, 2016

Greater weight increases the likelihood of hot flashes and night sweats during early stages of the menopause transition but reduces those symptoms throughout menopause and beyond, new UC Davis research published in the journal Menopause shows.

November 2016arrow

Gram-negative bacteria may influence Alzheimer's disease pathology

November 29, 2016

For the first time, researchers have found higher levels of Gram-negative bacteria antigens in brain samples from late-onset Alzheimer’s disease patients. Compared to controls, patients with Alzheimer's had much higher levels of lipopolysaccharide (LPS) and E coli K99 pili protein. In addition, The UC Davis team also found LPS molecules congregated with amyloid plaques, which have been linked to Alzheimer’s pathology and progression. The research was published today in the print edition of the journal Neurology.

Alarming health disparities could be prevented by breastfeeding

November 23, 2016

Black infants had over twice the deaths of whites attributable to lack of optimal breastfeeding, a new study published in the Journal of Pediatrics shows. Black infants also had over three times the rate of necrotizing enterocolitis, a devastating disease of preterm infants, attributable to suboptimal rates of feeding with their mother’s own milk.

Mobile health data may offer new pathways to better patient care

November 15, 2016

A UC Davis-led team has been awarded a $1.2 million grant from California Initiative to Advance Precision Medicine (CIAPM) to explore the use of personalized mobile health data to improve chronic disease management and care.